Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Min Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1875-740X; OpenAlex author ID A5100721749. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
45
Papers, trials and grants by year

2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 3 papers · 2024: 2 papers · 2025: 1 paper

Papers 14

  1. Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2025.06.020↗
  2. Endosomal Trafficking Bypassed by the RAB5B-CD109 Interplay Promotes Axonogenesis in KRAS-Mutant Pancreatic Cancer. Co-author DOI 10.1002/advs.202405092↗
  3. Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.drup.2024.101115↗
  4. Letter: Mendelian randomization-New perspective in inflammatory bowel disease and pancreatic cancer? Co-author DOI 10.1111/apt.17537↗
  5. Association between inflammatory bowel disease and pancreatic cancer: results from the two-sample Mendelian randomization study. Co-author DOI 10.3389/fonc.2023.1155123↗
  6. Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response. Co-author DOI 10.3390/cancers15051442↗
  7. TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.665265↗
  8. Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival. Co-author DOI 10.21037/atm.2020.03.98↗
  9. Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysis. Co-author DOI 10.2147/cmar.s196951↗
  10. Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2019.00773↗
  11. Revision of Surgical Margin under Frozen Section to Achieve R0 Status on Survival in Patients with Pancreatic Cancer. Co-author DOI 10.1007/s11605-018-3806-x↗
  12. Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00125-014-3481-8↗
  13. Metabolic phenotypes in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0115153↗
  14. Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of β-cell. Co-author DOI 10.1186/1479-5876-12-92↗

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xingchen Peng · 2 shared papers, 2023 · strength 0.50
  2. Lusheng Wei · 2 shared papers, 2024–2025 · strength 0.40
  3. Dingwen Zhang · 2 shared papers, 2024–2025 · strength 0.40
  4. Baohua Hou · 4 shared papers, 2018–2020 · strength 0.39
  5. Zhuo Kui Wu · 2 shared papers, 2023–2024 · strength 0.38
  6. Jiabin Yang · 2 shared papers, 2023–2024 · strength 0.38
  7. Yu Zhou · 3 shared papers, 2015–2023 · strength 0.32
  8. Zhixiang Jian · 3 shared papers, 2018–2019 · strength 0.28
  9. Rufu Chen · 2 shared papers, 2015–2025 · strength 0.25
  10. Rufu Chen · 2 shared papers, 2015–2023 · strength 0.24
  11. Huiheng Ning · 1 shared paper, 2025 · strength 0.21
  12. Kang Chen · 1 shared paper, 2025 · strength 0.21
  13. Qingling Zhang · 1 shared paper, 2025 · strength 0.21
  14. Minmin Chen · 1 shared paper, 2025 · strength 0.21
  15. Zemin Zhang · 1 shared paper, 2025 · strength 0.21
  16. Gordon Brent Mills · 1 shared paper, 2024 · strength 0.20
  17. Minmin Chen · 1 shared paper, 2024 · strength 0.20
  18. Wei-Feng Hong · 1 shared paper, 2024 · strength 0.20
  19. Haosheng Jin · 2 shared papers, 2019 · strength 0.19
  20. Liangtang Zeng · 1 shared paper, 2023 · strength 0.19
  21. Leyi Huang · 1 shared paper, 2023 · strength 0.19
  22. Rufu Chen · 1 shared paper, 2024 · strength 0.19
  23. Chao Yu · 1 shared paper, 2024 · strength 0.19
  24. Changhao Chen · 1 shared paper, 2024 · strength 0.19
  25. Yuming Luo · 1 shared paper, 2024 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.